Health News Today: Ebola Cases in Congo Top 11,000

The latest health news today from central Africa is a grim milestone. Congo's Ebola outbreak has topped 11,000 cases, the government said on Wednesday, a stark figure that underlines how severe the situation has become as the country struggles with the relentless spread of the disease. According to the latest health ministry data, 11,042 people have now been infected with the deadly virus, and 5,387 of them have died, nearly half of everyone confirmed to have caught it, in what has become Congo's deadliest outbreak on record.

The figures, released on Tuesday and reported around the world on Wednesday, confirm that the outbreak is no longer only a national emergency for the Democratic Republic of the Congo. It is now the second-largest and second-deadliest Ebola outbreak ever recorded anywhere, behind only the West African epidemic of 2014 to 2016, which infected more than 28,600 people and killed more than 11,000.

The outbreak was declared in mid-May, and in the six months since then Congolese authorities have struggled to contain it. Armed conflict, a health system in crisis, poor roads and violence from residents fuelled by mistrust and misinformation have all stood in the way of the response. The virus responsible, the rare Bundibugyo strain of Ebola, has no known vaccine and no approved specific treatment, and it has now spread to eight of the country's 26 provinces.

Health News Today: The Numbers Behind Congo's Deadliest Outbreak

The headline figures tell the story in the starkest possible terms. Confirmed infections now total 11,042, and 5,387 people have died, according to the health ministry data released on Tuesday. That is a case fatality ratio of close to 49 per cent, meaning roughly one in every two people confirmed to have contracted the virus has died from it. The World Health Organization had reported 10,668 confirmed cases and 5,198 deaths as of November 3, so the latest figures show about 374 new infections and about 189 more deaths in roughly a week.

The scale of the outbreak is what makes it historic. It is the largest and deadliest Ebola outbreak in Congo's history, and the second-largest and second-deadliest on record anywhere in the world. The only outbreak larger was the West African epidemic of 2014 to 2016, which swept through Guinea, Liberia and Sierra Leone, infected more than 28,600 people and killed more than 11,000.

The geography of the outbreak shows how far it has travelled from its starting point. Cases have been confirmed in eight of the country's 26 provinces and in 67 health zones, up from just three zones in the first days after the outbreak was declared.

Cases have also been reported in Kenya and Nigeria, a development that raises the stakes for the whole region. Cross-border spread is one of the scenarios the World Health Organization watches most closely, because it can turn a national outbreak into a regional one.

The Bundibugyo Strain: No Vaccine, No Approved Treatment

At the centre of the crisis is the particular virus causing it. The outbreak is caused by the Bundibugyo species of the Ebola virus, a rare strain that was first identified in Uganda in 2007. It is one of several distinct species of Ebola-causing viruses, and it behaves differently from the better-known Zaire strain, which has caused most of the large outbreaks in history, including the West African epidemic and the 2018 to 2020 outbreak in eastern Congo.

The most important difference is that there is no licensed vaccine and no approved specific treatment for the Bundibugyo strain. The licensed Ervebo vaccine, the one that transformed the response to Ebola in recent years, targets the Zaire strain only. It offers no protection against Bundibugyo. That means the single most powerful tool developed against Ebola in the past decade is not available for this outbreak, and health workers are fighting the virus with the methods that were available before the vaccine existed.

Care for patients therefore focuses on supportive treatment, keeping people hydrated, managing fever and pain, treating secondary infections and giving the body's own defences the best possible chance. Survival depends heavily on how quickly a patient reaches care. People who are treated early, in a properly equipped treatment centre, have a far better chance than those who stay at home until the disease is advanced.

There is, however, one source of hope. The World Health Organization has supported the launch of the Tumaini vaccine trial in Bunia, in Ituri province, which began enrolling participants on October 23. The trial is testing an experimental vaccine candidate against the Bundibugyo strain. India's Serum Institute is also collaborating with Oxford University on an experimental vaccine candidate that is being considered for a WHO-supported trial. Neither candidate is licensed yet, but if either shows promise it could change the course of this outbreak and of every Bundibugyo outbreak that follows.

Why the Outbreak Keeps Spreading

The outbreak was declared on May 15, 2026, and two days later the World Health Organization designated it a public health emergency of international concern, the highest level of alarm the agency can sound. The declaration was a recognition that the outbreak was spreading, that the country could not contain it alone, and that the international community needed to mobilise. Six months on, the case count shows how difficult that task has proved.

The obstacles are not medical alone. They are the conditions in which the outbreak is unfolding. Armed conflicts in eastern Congo have made large areas dangerous for health workers, and attacks on treatment centres and response teams have been a recurring feature of Ebola outbreaks in the region. A health system already in crisis has too few staff, too little equipment and too few treatment beds for the scale of the caseload. Poor roads slow the movement of patients, samples and supplies, and in some areas the only way to reach a village is on foot or by motorbike.

Mistrust and misinformation have proved just as damaging. Violence from residents, fuelled by rumours about the disease and suspicion of outsiders, has driven some communities to hide cases, refuse treatment and attack response teams. When families hide a sick relative, the virus spreads within the household, and when a death is buried in secret, without the safe burial practices that prevent transmission, it can seed a whole new chain of infections. The pattern is familiar from earlier outbreaks, and it is one of the hardest problems in public health to solve, because it cannot be fixed with medicine alone. It requires trust, and trust is built slowly, village by village, by local health workers and community leaders who speak the language and understand the fears.

A History of Ebola in Congo

Congo is where Ebola began. The virus was first identified in 1976, near the Ebola River in the north of what was then Zaire, in an outbreak that killed 280 of the 318 people infected. Since then the country has faced repeated outbreaks, more than a dozen in all, more than any other country in the world. The virus lives in the forests of central Africa, and it spills over into people when they come into contact with infected animals, most likely fruit bats. Once it reaches a person, it spreads through contact with the bodily fluids of someone who is sick or has died from the disease.

The country's long experience with Ebola has produced hard-won knowledge. Congolese health workers are among the most experienced Ebola responders in the world, and the country has built up systems for surveillance, contact tracing and safe burial that have stopped many outbreaks quickly. Several outbreaks in recent years were contained within weeks, with only a handful of cases. The current outbreak is different because of its scale, its geography and the strain involved, and because it is unfolding in a region where conflict has eroded the very systems that would normally contain it.

The 2018 to 2020 outbreak in the eastern provinces of North Kivu and Ituri was the warning. It lasted almost two years, infected more than 3,400 people and killed more than 2,200, and it was the first Ebola outbreak to unfold in an active conflict zone. It was also the outbreak in which the Ervebo vaccine was deployed at scale for the first time, in a ring vaccination strategy that protected the contacts of confirmed cases and the contacts of those contacts. The vaccine helped to end that outbreak, and it has since become a standard part of the response to Zaire strain outbreaks. The fact that it cannot be used against Bundibugyo is the cruelest twist of the current crisis.

What Happens Next

The immediate future of the outbreak will be measured in weekly case counts. If the numbers keep rising at the current pace, the outbreak will move further up the list of the worst Ebola epidemics in history, and the strain on Congo's health system will deepen. Health authorities will be watching whether the virus reaches new provinces, whether the cross-border cases reported in Kenya and Nigeria develop into sustained transmission, and whether the violence and mistrust that have hampered the response begin to ease.

The vaccine trials will be watched just as closely. The Tumaini trial in Bunia, which began enrolling participants on October 23, is the most concrete hope for a tool that could change the trajectory of the outbreak. Early results will be scrutinised by health officials around the world, because a vaccine that works against the Bundibugyo strain would fill one of the largest remaining gaps in the world's defences against Ebola. But trials take time, and an outbreak does not wait. Even in the best case, a vaccine is months away from being available at scale, and the people falling ill now need care, isolation and safe burial today.

The international response will also be a test. The World Health Organization has warned that sustained transmission in the Democratic Republic of the Congo, particularly in areas affected by insecurity, continues to pose a significant public health challenge. That warning is a call for support, for funding, for health workers and for supplies, and for the political attention that a crisis in a conflict zone can struggle to hold. Six months on, the case count is the measure of whether that support has been enough.

For the people of Congo, the milestone of 11,000 cases is not an abstraction. It is a crisis that has lasted half a year, spread across eight provinces and killed nearly half of everyone it has infected. What this outbreak needs now is the combination that worked before: resources, access, and the trust of the communities where the virus is spreading.

Source: AP News